{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:20:21Z","timestamp":1790612421849,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100020950","name":"National Science and Technology Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010101","name":"Taichung Veterans General Hospital","doi-asserted-by":"publisher","award":["TCVGH-VTA114V211"],"award-info":[{"award-number":["TCVGH-VTA114V211"]}],"id":[{"id":"10.13039\/501100010101","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010101","name":"Taichung Veterans General Hospital","doi-asserted-by":"publisher","award":["TCVGH-1144302C"],"award-info":[{"award-number":["TCVGH-1144302C"]}],"id":[{"id":"10.13039\/501100010101","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010101","name":"Taichung Veterans General Hospital","doi-asserted-by":"publisher","award":["TCVGH-1123603C"],"award-info":[{"award-number":["TCVGH-1123603C"]}],"id":[{"id":"10.13039\/501100010101","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010101","name":"Taichung Veterans General Hospital","doi-asserted-by":"publisher","award":["TCVGH-1144302D"],"award-info":[{"award-number":["TCVGH-1144302D"]}],"id":[{"id":"10.13039\/501100010101","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010101","name":"Taichung Veterans General Hospital","doi-asserted-by":"publisher","award":["TCVGH-1137306D"],"award-info":[{"award-number":["TCVGH-1137306D"]}],"id":[{"id":"10.13039\/501100010101","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010101","name":"Taichung Veterans General Hospital","doi-asserted-by":"publisher","award":["TCVGH-1137313C"],"award-info":[{"award-number":["TCVGH-1137313C"]}],"id":[{"id":"10.13039\/501100010101","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 113-2314-B-075A-003"],"award-info":[{"award-number":["NSTC 113-2314-B-075A-003"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.numecd.2025.104358","type":"journal-article","created":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:18:34Z","timestamp":1757769514000},"page":"104358","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The impact of combined trajectories of serum uric acid, renal function, and blood pressure on long-term survival in patients with chronic kidney disease"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6119-0587","authenticated-orcid":false,"given":"Shang-Feng","family":"Tsai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ju","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Lin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2 Suppl 1","key":"10.1016\/j.numecd.2025.104358_bib1","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","year":"2002","journal-title":"Am J Kidney Dis Offic J Nation Kidney Found"},{"issue":"3 Suppl 3","key":"10.1016\/j.numecd.2025.104358_bib2","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1053\/j.ajkd.2008.07.048","article-title":"Conceptual model of CKD: applications and implications","volume":"53","author":"Levey","year":"2009","journal-title":"Am J Kidney Dis Offic J Nation Kidney Found"},{"issue":"18","key":"10.1016\/j.numecd.2025.104358_bib3","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1056\/NEJMra1700312","article-title":"Nutritional management of chronic kidney disease","volume":"377","author":"Kalantar-Zadeh","year":"2017","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.numecd.2025.104358_bib4","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1681\/ASN.2015040369","article-title":"Ketoanalogue-supplemented vegetarian very low-protein diet and CKD progression","volume":"27","author":"Garneata","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"26","key":"10.1016\/j.numecd.2025.104358_bib5","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJM198512263132601","article-title":"Effect of captopril on heavy proteinuria in azotemic diabetics","volume":"313","author":"Taguma","year":"1985","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.numecd.2025.104358_bib6","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The collaborative study group","volume":"329","author":"Lewis","year":"1993","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.numecd.2025.104358_bib7","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.numecd.2025.104358_bib8","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.numecd.2025.104358_bib9","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1056\/NEJMoa011489","article-title":"The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes","volume":"345","author":"Parving","year":"2001","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.numecd.2025.104358_bib10","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1056\/NEJMoa042167","article-title":"Preventing microalbuminuria in type 2 diabetes","volume":"351","author":"Ruggenenti","year":"2004","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.numecd.2025.104358_bib11","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.2337\/dc16-er09","article-title":"Classification and diagnosis of diabetes. Sec. 2. In standards of Medical care in Diabetes-2016. Diabetes care 2016;39(Suppl. 1):S13-S22","volume":"39","year":"2016","journal-title":"Diabetes Care"},{"issue":"10184","key":"10.1016\/j.numecd.2025.104358_bib12","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/S0140-6736(19)30772-X","article-title":"Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial","volume":"393","author":"Heerspink","year":"2019","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.numecd.2025.104358_bib13","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.numecd.2025.104358_bib14","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1159\/000503712","article-title":"Design and baseline characteristics of the finerenone in reducing cardiovascular mortality and morbidity in diabetic kidney disease trial","volume":"50","author":"Ruilope","year":"2019","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.numecd.2025.104358_bib15","doi-asserted-by":"crossref","DOI":"10.1177\/2042018819865398","article-title":"The incretin pathway as a therapeutic target in diabetic kidney disease: a clinical focus on GLP-1 receptor agonists","volume":"10","author":"van Baar","year":"2019","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.numecd.2025.104358_bib16","doi-asserted-by":"crossref","unstructured":"Jha, V.; Wang, A. Y.; Wang, H. The impact of CKD identification in large countries: the burden of illness. Nephrol Dial Transplant Ofic Pub Europ Dialysis Transplant Assoc- Europ Renal Assoc 2012, 27 Suppl 3, iii32-iii38. DOI: 10.1093\/ndt\/gfs113.[From NLM].","DOI":"10.1093\/ndt\/gfs113"},{"issue":"37","key":"10.1016\/j.numecd.2025.104358_bib17","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1093\/eurheartj\/ehx322","article-title":"Blood pressure variability and cardiovascular prognosis: implications for clinical practice","volume":"38","author":"Weber","year":"2017","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.numecd.2025.104358_bib18","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1161\/HYPERTENSIONAHA.122.20376","article-title":"Visit-to-Visit blood pressure variability and cardiovascular outcomes in patients receiving intensive versus standard blood pressure control: insights from the STEP trial","volume":"80","author":"Yu","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.numecd.2025.104358_bib19","doi-asserted-by":"crossref","DOI":"10.1177\/2040622319898370","article-title":"The variability of glycated hemoglobin is associated with renal function decline in patients with type 2 diabetes","volume":"11","author":"Lee","year":"2020","journal-title":"Ther Adv Chronic Dis"},{"issue":"3","key":"10.1016\/j.numecd.2025.104358_bib20","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S2213-8587(18)30136-0","article-title":"Glycaemic variability in diabetes: clinical and therapeutic implications","volume":"7","author":"Ceriello","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"30","key":"10.1016\/j.numecd.2025.104358_bib21","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000029589","article-title":"The effect of trajectory of serum uric acid on survival and renal outcomes in patients with stage 3 chronic kidney disease","volume":"101","author":"Lee","year":"2022","journal-title":"Medicine (Baltim)"},{"issue":"8","key":"10.1016\/j.numecd.2025.104358_bib22","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1161\/CIRCRESAHA.122.321762","article-title":"Hypertension as cardiovascular risk factor in chronic kidney disease","volume":"132","author":"Burnier","year":"2023","journal-title":"Circ Res"},{"issue":"10","key":"10.1016\/j.numecd.2025.104358_bib23","first-page":"Cd008564","article-title":"Blood pressure targets for hypertension in people with chronic renal disease","volume":"10","author":"Erviti","year":"2024","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.numecd.2025.104358_bib24","doi-asserted-by":"crossref","DOI":"10.5812\/numonthly.7(3)2015.27233","article-title":"Associations between hyperuricemia and chronic kidney disease: a review","volume":"7","author":"Prasad Sah","year":"2015","journal-title":"Nephrourol Mon"},{"issue":"12","key":"10.1016\/j.numecd.2025.104358_bib25","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s11906-020-01116-3","article-title":"Management of hyperuricemia in patients with chronic kidney disease: a focus on renal protection","volume":"22","author":"Kielstein","year":"2020","journal-title":"Curr Hypertens Rep"},{"issue":"10","key":"10.1016\/j.numecd.2025.104358_bib26","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s11906-016-0684-z","article-title":"Hypertension, and chronic kidney disease: an emerging association","volume":"18","author":"Mallat","year":"2016","journal-title":"Curr Hypertens Rep"},{"issue":"6","key":"10.1016\/j.numecd.2025.104358_bib27","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1053\/j.ackd.2012.07.009","article-title":"Renal transport of uric acid: evolving concepts and uncertainties","volume":"19","author":"Bobulescu","year":"2012","journal-title":"Adv Chron Kidney Dis"},{"issue":"1","key":"10.1016\/j.numecd.2025.104358_bib28","doi-asserted-by":"crossref","first-page":"5119","DOI":"10.1038\/s41598-024-55809-9","article-title":"Association between urinary uric acid excretion and kidney outcome in patients with CKD","volume":"14","author":"Asahina","year":"2024","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.numecd.2025.104358_bib29","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1001\/archinternmed.2008.605","article-title":"Risk factors for end-stage renal disease: 25-Year follow-up","volume":"169","author":"Hsu","year":"2009","journal-title":"Arch Intern Med"},{"issue":"8","key":"10.1016\/j.numecd.2025.104358_bib30","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1093\/ndt\/gfq740","article-title":"Serum uric acid is a GFR-independent long-term predictor of acute and chronic renal insufficiency: the Jerusalem Lipid Research Clinic cohort study","volume":"26","author":"Ben-Dov","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.numecd.2025.104358_bib31","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1681\/ASN.2004030208","article-title":"Risk factors for development of decreased kidney function in a southeast Asian population: a 12-year cohort study","volume":"16","author":"Domrongkitchaiporn","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.numecd.2025.104358_bib32","doi-asserted-by":"crossref","first-page":"237","DOI":"10.14423\/SMJ.0000000000001516","article-title":"Hypertension in chronic kidney disease: an update on diagnosis and management","volume":"116","author":"Gupta","year":"2023","journal-title":"South Med J"},{"issue":"32","key":"10.1016\/j.numecd.2025.104358_bib33","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.2174\/0113816128266582231031111516","article-title":"Review on molecular mechanism of hypertensive nephropathy","volume":"29","author":"Peng","year":"2023","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.numecd.2025.104358_bib34","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/132405","article-title":"Hypertension in chronic kidney disease: navigating the evidence","volume":"2011","author":"Tedla","year":"2011","journal-title":"Int J Hypertens"},{"issue":"7","key":"10.1016\/j.numecd.2025.104358_bib35","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1001\/archinte.1987.00370070103015","article-title":"Secondary hypertension in a blood pressure clinic","volume":"147","author":"Sinclair","year":"1987","journal-title":"Arch Intern Med"},{"issue":"8","key":"10.1016\/j.numecd.2025.104358_bib36","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/ndt\/gfu183","article-title":"Blood pressure, albuminuria and renal dysfunction: the 'chicken or egg' dilemma","volume":"29","author":"Viazzi","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1016\/j.numecd.2025.104358_bib37","doi-asserted-by":"crossref","DOI":"10.1093\/ije\/dyw282","article-title":"Cohort profile: the Taiwan MJ cohort: half a million Chinese with repeated health surveillance data","volume":"46","author":"Wu","year":"2017","journal-title":"Int J Epidemiol"},{"issue":"4","key":"10.1016\/j.numecd.2025.104358_bib38","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","article-title":"Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate","volume":"145","author":"Levey","year":"2006","journal-title":"Ann Intern Med"},{"issue":"2\u20133","key":"10.1016\/j.numecd.2025.104358_bib39","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000360229","article-title":"Group-based trajectory modeling: an overview","volume":"65","author":"Nagin","year":"2014","journal-title":"Ann Nutr Metabol"},{"issue":"1","key":"10.1016\/j.numecd.2025.104358_bib40","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1037\/1082-989X.6.1.18","article-title":"Analyzing developmental trajectories of distinct but related behaviors: a group-based method","volume":"6","author":"Nagin","year":"2001","journal-title":"Psychol Methods"},{"key":"10.1016\/j.numecd.2025.104358_bib41","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1146\/annurev.clinpsy.121208.131413","article-title":"Group-based trajectory modeling in clinical research","volume":"6","author":"Nagin","year":"2010","journal-title":"Annu Rev Clin Psychol"},{"issue":"2","key":"10.1016\/j.numecd.2025.104358_bib42","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2215\/CJN.03670807","article-title":"Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?","volume":"3","author":"Stenvinkel","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.numecd.2025.104358_bib43","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/01.mnh.0000168336.67499.c0","article-title":"Vascular calcifications and cardiovascular disease in uremia","volume":"14","author":"London","year":"2005","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"11","key":"10.1016\/j.numecd.2025.104358_bib44","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","article-title":"Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options","volume":"143","author":"Jankowski","year":"2021","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.numecd.2025.104358_bib45","doi-asserted-by":"crossref","first-page":"192","DOI":"10.7326\/0003-4819-156-7-201204030-00412","article-title":"Update in nephrology: evidence published in 2011","volume":"157","author":"Chonchol","year":"2012","journal-title":"Ann Intern Med"},{"issue":"9784","key":"10.1016\/j.numecd.2025.104358_bib46","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.numecd.2025.104358_bib47","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","author":"Wanner","year":"2005","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.numecd.2025.104358_bib48","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa0810177","article-title":"Rosuvastatin and cardiovascular events in patients undergoing hemodialysis","volume":"360","author":"Fellstr\u00f6m","year":"2009","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.numecd.2025.104358_bib49","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.032186","article-title":"Association of the intensive blood pressure target and cardiovascular outcomes in the population with chronic kidney disease: a retrospective study in Korea","volume":"13","author":"Yoon","year":"2024","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.numecd.2025.104358_bib50","article-title":"The effect of different levels of systolic blood pressure control on new-onset chronic kidney disease in hypertension multimorbidity","volume":"14","author":"Yu","year":"2024","journal-title":"Sci Rep"},{"issue":"3s","key":"10.1016\/j.numecd.2025.104358_bib51","first-page":"S1","article-title":"Clinical practice guideline for the management of blood pressure in chronic kidney disease","volume":"99","year":"2021","journal-title":"Kidney Int"},{"issue":"9349","key":"10.1016\/j.numecd.2025.104358_bib52","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.numecd.2025.104358_bib53","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-49557-4","article-title":"Low on-treatment diastolic blood pressure and cardiovascular outcome: a post-hoc analysis using NHLBI SPRINT research Materials","volume":"9","author":"Sobieraj","year":"2019","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.numecd.2025.104358_bib54","doi-asserted-by":"crossref","first-page":"700","DOI":"10.2174\/1381612825666190408122557","article-title":"Hyperuricemia and cardiovascular disease","volume":"25","author":"Zhang","year":"2019","journal-title":"Curr Pharm Des"},{"issue":"1","key":"10.1016\/j.numecd.2025.104358_bib55","doi-asserted-by":"crossref","first-page":"7","DOI":"10.7326\/0003-4819-131-1-199907060-00003","article-title":"Serum uric acid and risk for cardiovascular disease and death: the framingham heart study","volume":"131","author":"Culleton","year":"1999","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.numecd.2025.104358_bib56","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/BOR.0b013e3283432dd3","article-title":"Uric acid in heart disease: a new C-reactive protein?","volume":"23","author":"Krishnan","year":"2011","journal-title":"Curr Opin Rheumatol"},{"issue":"17","key":"10.1016\/j.numecd.2025.104358_bib57","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra0800885","article-title":"Uric acid and cardiovascular risk","volume":"359","author":"Feig","year":"2008","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.numecd.2025.104358_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0020076","article-title":"Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: prospective study and meta-analysis","volume":"2","author":"Wheeler","year":"2005","journal-title":"PLoS Med"},{"key":"10.1016\/j.numecd.2025.104358_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2020.07.006","article-title":"Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease","volume":"80","author":"Borghi","year":"2020","journal-title":"Eur J Intern Med"},{"issue":"10","key":"10.1016\/j.numecd.2025.104358_bib60","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1097\/HJH.0000000000003807","article-title":"Asymptomatic hyperuricemia: to treat or not a threat? A clinical and evidence-based approach to the management of hyperuricemia in the context of cardiovascular diseases","volume":"42","author":"Fiori","year":"2024","journal-title":"J Hypertens"},{"issue":"7","key":"10.1016\/j.numecd.2025.104358_bib61","article-title":"Update of Chinese guidelines for diagnosis and treatment of hyperuricemia and gout part I: recommendations for general patients","volume":"28","author":"Sun","year":"2024","journal-title":"Int J Rheum Dis 2025"},{"issue":"2","key":"10.1016\/j.numecd.2025.104358_bib62","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.dsx.2020.01.007","article-title":"Management of asymptomatic hyperuricemia: Integrated Diabetes & Endocrine Academy (IDEA) consensus statement","volume":"14","author":"Valsaraj","year":"2020","journal-title":"Diabetes Metabol Syndr"},{"key":"10.1016\/j.numecd.2025.104358_bib63","article-title":"The fifth element: is vascular dysfunction an intrinsic feature of gout?","volume":"72s","author":"Pillinger","year":"2025","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.numecd.2025.104358_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2019.106565","article-title":"Uric acid: from a biological advantage to a potential danger. A focus on cardiovascular effects","volume":"120","author":"Cortese","year":"2019","journal-title":"Vascul Pharmacol"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475325005125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475325005125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T21:56:53Z","timestamp":1773179813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475325005125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":64,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0939475325005125"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2025.104358","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of combined trajectories of serum uric acid, renal function, and blood pressure on long-term survival in patients with chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2025.104358","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104358"}}